Hält derzeit Positionen bei Thermo Fisher Scientific Inc and Editas Medicine Inc
Position | Company | Period |
---|---|---|
Director | Thermo Fisher Scientific Inc | 8. November 2018 - |
Independent Chairman of the Board | Editas Medicine Inc | 27. März 2018 - |
Independent Director | Insulet Corp | 9. August 2017 - 25. Januar 2019 |
Independent Director | PerkinElmer Inc | 1. Januar 2004 - 28. April 2015 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2022-01-04 | 2022-01-03 |
Editas Medicine Inc
(EDIT)
|
V Verkauf |
18.252
-19.4%
26,95491.979 USD |
18.252 -19.4% | 26,95 | 491.979 USD | |
2021-10-20 | 2021-10-18 |
Editas Medicine Inc
(EDIT)
|
V Verkauf |
13.805
-19.3%
38,03525.033 USD |
13.805 -19.3% | 38,03 | 525.033 USD | |
2021-03-04 | 2021-03-02 |
Editas Medicine Inc
(EDIT)
|
K Kauf |
25.000
+250.0%
46,271.156.800 USD |
25.000 +250.0% | 46,27 | 1.156.800 USD | |
2004-10-20 | 2004-10-18 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-3.8%
57,8186.711 USD |
1.500 -3.8% | 57,81 | 86.711 USD | |
2004-10-20 | 2004-10-18 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-3.7%
58,0587.073 USD |
1.500 -3.7% | 58,05 | 87.073 USD | |
2004-10-20 | 2004-10-18 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-3.6%
57,5086.250 USD |
1.500 -3.6% | 57,50 | 86.250 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.000
-2.3%
60,0060.000 USD |
1.000 -2.3% | 60,00 | 60.000 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-3.4%
59,9589.925 USD |
1.500 -3.4% | 59,95 | 89.925 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.325
-2.9%
60,3379.937 USD |
1.325 -2.9% | 60,33 | 79.937 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
175
-100.0%
60,3310.558 USD |
175 -100.0% | 60,33 | 10.558 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-89.6%
60,1290.180 USD |
1.500 -89.6% | 60,12 | 90.180 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.000
-37.4%
62,3862.380 USD |
1.000 -37.4% | 62,38 | 62.380 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-35.9%
62,7794.158 USD |
1.500 -35.9% | 62,77 | 94.158 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-26.4%
62,8594.268 USD |
1.500 -26.4% | 62,85 | 94.268 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-20.9%
62,4893.723 USD |
1.500 -20.9% | 62,48 | 93.723 USD | |
2004-07-27 | 2004-07-26 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-2.6%
53,4480.157 USD |
1.500 -2.6% | 53,44 | 80.157 USD | |
2004-07-27 | 2004-07-26 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-2.5%
53,3580.025 USD |
1.500 -2.5% | 53,35 | 80.025 USD | |
2004-07-27 | 2004-07-19 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-2.6%
53,5180.259 USD |
1.500 -2.6% | 53,51 | 80.259 USD | |
2004-07-20 | 2004-07-19 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-2.4%
57,9686.933 USD |
1.500 -2.4% | 57,96 | 86.933 USD | |
2004-07-20 | 2004-07-19 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-2.4%
57,9086.849 USD |
1.500 -2.4% | 57,90 | 86.849 USD | |
2004-07-20 | 2004-07-19 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-2.3%
57,9286.877 USD |
1.500 -2.3% | 57,92 | 86.877 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.000
-1.5%
60,7060.700 USD |
1.000 -1.5% | 60,70 | 60.700 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-2.2%
60,5090.755 USD |
1.500 -2.2% | 60,50 | 90.755 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-2.2%
60,4890.723 USD |
1.500 -2.2% | 60,48 | 90.723 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-2.1%
60,6991.037 USD |
1.500 -2.1% | 60,69 | 91.037 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.000
-1.4%
62,0762.070 USD |
1.000 -1.4% | 62,07 | 62.070 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-2.1%
61,9992.985 USD |
1.500 -2.1% | 61,99 | 92.985 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
925
-1.3%
61,9857.335 USD |
925 -1.3% | 61,98 | 57.335 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
575
-100.0%
61,9835.641 USD |
575 -100.0% | 61,98 | 35.641 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-72.3%
63,9795.959 USD |
1.500 -72.3% | 63,97 | 95.959 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.000
-3.3%
61,3261.320 USD |
1.000 -3.3% | 61,32 | 61.320 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-4.7%
61,2991.932 USD |
1.500 -4.7% | 61,29 | 91.932 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-4.5%
61,2691.896 USD |
1.500 -4.5% | 61,26 | 91.896 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
GV Geplanter Verkauf |
1.500
-4.3%
61,3792.051 USD |
1.500 -4.3% | 61,37 | 92.051 USD | |
2004-05-14 | 2004-05-14 |
PerkinElmer Inc
(PKI)
|
K Kauf |
5.000
+124.4%
18,3391.650 USD |
5.000 +124.4% | 18,33 | 91.650 USD |